I’m not a fan of the ‘fighting cancer’ metaphor as a battle cry; scores tallied—winners and losers. I prefer the judo allegory: leveraging one’s full, innate healing capacity—utilizing numerous tools and approaches—to make cancer, or any other condition or pathology, more difficult to take root or gain an upper hand. For those with cancer, it’s […]
Powerful lifestyle change rarely coincides with a new calendar year. Health creation habits are acquired via incremental, consistent modifications over time.
There is good news in the advancement of chemo-free approaches to managing chronic lymphocytic leukemia, and I am thrilled to share it with you. Results of the phase III ECOG trial found that the combination of ibrutinib (Imbruvica) plus rituximab (Rituxan) came out superior to the chemotherapy and immunotherapy (chemoimmunotherapy) grouping of fludarabine, cyclophosphamide, and rituximab, known as FCR.
A new, troubling report from Truth In Advertising suggests some cancer hospitals are guilty of deceiving patients about their chances of survival, because they give the initial impression that the patient will be treated under the umbrella of precision cancer care, when, in fact, it (precision cancer care) is not available for many types of cancer.
Does the consumption of ‘clean’ foods do a better job at preventing cancer than, say, what the majority of the U.S. population eats—namely produce and processed foodstuffs containing pesticide and herbicide residue, antibiotics, and growth hormones?
Glenn shares how THC and CBD are being used in a clinical setting—and where we are in terms of current science supporting medical marijuana and CBD oil for symptom relief and as an anticancer agent. He also shares his own history with cannabinoids.
Guest post by Dr. Nancy Novack–a clinical psychologist, cancer thriver, and expert on all things cancer financial matters–shares important resources that all patients, oncologists, and healthcare professionals should be aware of to lessen the burden of cancer.
Glenn explores the phenomena of cancer outliers, exceptional responders and radical remissions in the age of precision medicine, biomedical informatics and integrative oncology.
A recently published paper in the esteemed JAMA Oncology triggered dire headlines, including this one in The New York Times:
“People who used herbs, acupuncture and other complementary treatments tended to die earlier than those who didn’t.”
Really? Is this true?
We enrolled dad into in-home hospice a couple weeks ago. It’s been a challenging process. Mine is a nuclear family of five, nine different cancers between us. No one has yet succumbed to the disease.